EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A Novel SIL1 Variant (p.E342K) Associated with Marinesco–Sjögren Syndrome Impairs Protein Stability and Function

Anna Giulia Ruggieri, Nikolaos M Marinakis iD, Laura Amodei iD, Francesca Potenza, Afrodite Kampouraki, Faidon-Nikolaos Tilemis iD, Laura Pietrangelo iD, Marianna Viele, Federica Di Marco iD, Piero Del Boccio iD, Federica Di Cintio iD, Nikoletta Selenti und 5 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311310 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna Giulia Ruggieri und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Innovative Technologies in Medicine and Dentistry, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy. Hauptthemen laut MEDLINE: Spinocerebellar Degenerations. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, Telethon Foundation, Funded by European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marinesco–Sjögren syndrome (MSS) is a rare autosomal recessive neuromuscular disorder marked by ataxia, muscle weakness, cataracts, and often intellectual and skeletal abnormalities. It is commonly caused by loss-of-function variants in the SIL1 gene, which impair binding immunoglobulin protein (BiP) function, leading to protein misfolding and activation of the unfolded protein response. In a 2-year-old patient with typical MSS symptoms, we identified a previously unreported c.1024G>A (p.E342K) variant in SIL1 via whole-exome sequencing. The pathogenicity of this Sil1 variant was supported by evidence of structural changes revealed through in silico predictions, circular dichroism, and native gel electrophoresis. Patient-derived fibroblasts exhibited reduced Sil1 protein levels, likely due to misfolding and degradation, which was partially rescued by proteasome inhibition. Proteomics revealed a profile similar to known MSS cases and a distinctive MSS transcriptional signature. Ultrastructural analysis confirmed typical MSS features, such as autophagic vacuoles and lipid droplets. Although the p.E342K phenotype appears milder than the reference pathogenic variant R111X, our findings support the reclassification of this novel variant as pathogenic, in accordance with the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) 2015 guidelines and the refinements proposed by the Clinical Genome Resource Sequence Variant Interpretation (ClinGen SVI) recommendations. Furthermore, the overall evidence also provides important insights into the genotype–phenotype correlation and the underlying pathogenic mechanism of the p.E342K variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinocerebellar DegenerationsChild, PreschoolFemaleHumansExome SequencingProtein StabilityGuanine Nucleotide Exchange Factors

Stichwörter der Autor:innen

VUSataxiachaperonesmyopathyneurodegenerative diseaseproteomicsvariant of unknown significance

Substanzen

SIL1 protein, humanGuanine Nucleotide Exchange Factors

Autor:innen und Institutionen

  • Department of Innovative Technologies in Medicine and Dentistry, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
  • Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
  • Laboratory of Medical Genetics, Medical School, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
  • Laboratory of Genetics, Department of Medicine, Democritus University of Thrace, 681 00 Alexandroupolis, Greece.
  • Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
  • Department of Sciences, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.

ORCID-Profile: Nikolaos M Marinakis, Laura Amodei, Faidon-Nikolaos Tilemis, Laura Pietrangelo, Federica Di Marco, Piero Del Boccio, Federica Di Cintio, Adriana Erica Miele, Michele Sallese

Förderung

  • Ministero dell'università e della ricerca
  • Telethon Foundation
  • Funded by European Union
  • NextGenerationEU—MUR, Fondo Promozione e Sviluppo
  • Italian Telethon ONLUS Foundation, Rome, Italy
  • European Union—NextGenerationEU

Zitieren

APA

Ruggieri, A. G., Marinakis, N. M., Amodei, L., Potenza, F., Kampouraki, A., Tilemis, F. N., Pietrangelo, L., Viele, M., Di Marco, F., Del Boccio, P., Di Cintio, F., Selenti, N., Valari, M., Federici, L., Miele, A. E., Sallese, M., & Makrythanasis, P. (2025). A Novel SIL1 Variant (p.E342K) Associated with Marinesco–Sjögren Syndrome Impairs Protein Stability and Function. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311310

Vancouver

Ruggieri AG, Marinakis NM, Amodei L, Potenza F, Kampouraki A, Tilemis FN, et al. A Novel SIL1 Variant (p.E342K) Associated with Marinesco–Sjögren Syndrome Impairs Protein Stability and Function. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311310

BibTeX
@article{Ruggieri2025,
  author = {Ruggieri, Anna Giulia and Marinakis, Nikolaos M and Amodei, Laura and Potenza, Francesca and Kampouraki, Afrodite and Tilemis, Faidon-Nikolaos and Pietrangelo, Laura and Viele, Marianna and Di Marco, Federica and Del Boccio, Piero and Di Cintio, Federica and Selenti, Nikoletta and Valari, Manthoula and Federici, Luca and Miele, Adriana Erica and Sallese, Michele and Makrythanasis, Periklis},
  title = {A Novel SIL1 Variant (p.E342K) Associated with Marinesco–Sjögren Syndrome Impairs Protein Stability and Function},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311310}
}
Kostenlos starten →